ArticlePharmaceuticals (Basel, Switzerland)2026
Multitarget Strategy for Treatment of Pulmonary Arterial Hypertension: Combination of Mesenchymal Cells with Novel PDE-4 Inhibitor.
Bruno Eduardo Dematté et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.